Deferasirox Sprinkle Granules and Piqray 250MG Daily Dose
Determining the interaction of Deferasirox Sprinkle Granules and Piqray 250MG Daily Dose and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Coadministration of alpelisib with inducers of CYP450 3A4 may reduce the plasma concentrations of alpelisib. The proposed mechanism, based on in vitro data, is increased clearance due to induction of CYP450 3A4, which is one of the routes of metabolism of alpelisib. According to the manufacturer, therapeutic efficacy of alpelisib may be reduced in the presence of potent CYP450 3A4 inducers; however, clinical data are lacking. Data are not available for mild to moderate CYP450 3A4 inducers. MANAGEMENT: Caution is recommended when alpelisib is used with CYP450 3A4 inducers. Pharmacologic effects of alpelisib should be monitored more closely whenever the inducer is added to or withdrawn from therapy. References "Product Information. Piqray (alpelisib)." Novartis Pharmaceuticals, East Hanover, NJ.
Professional:MONITOR: Coadministration of alpelisib with inducers of CYP450 3A4 may reduce the plasma concentrations of alpelisib. The proposed mechanism, based on in vitro data, is increased clearance due to induction of CYP450 3A4, which is one of the routes of metabolism of alpelisib. According to the manufacturer, therapeutic efficacy of alpelisib may be reduced in the presence of potent CYP450 3A4 inducers; however, clinical data are lacking. Data are not available for mild to moderate CYP450 3A4 inducers.
MANAGEMENT: Caution is recommended when alpelisib is used with CYP450 3A4 inducers. Pharmacologic effects of alpelisib should be monitored more closely whenever the inducer is added to or withdrawn from therapy.
- "Product Information. Piqray (alpelisib)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: deferasirox
Brand name: Exjade, Jadenu, Jadenu Sprinkle
Synonyms: Deferasirox
Generic Name: alpelisib
Brand name: Piqray
Synonyms: Alpelisib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferasirox Sprinkle Granules-Piqray 300MG Daily Dose
- Deferasirox Sprinkle Granules-Pirbuterol Inhalation
- Deferasirox Sprinkle Granules-Pirfenidone
- Deferasirox Sprinkle Granules-Pirmella 1/35
- Deferasirox Sprinkle Granules-Pirmella 7/7/7
- Deferasirox Sprinkle Granules-Piroxicam
- Piqray 250MG Daily Dose-Deferasirox Tablets
- Piqray 250MG Daily Dose-Deferasirox Tablets For Oral Suspension
- Piqray 250MG Daily Dose-Deferiprone
- Piqray 250MG Daily Dose-Deferiprone Oral Solution
- Piqray 250MG Daily Dose-Deferiprone Tablets
- Piqray 250MG Daily Dose-Deferoxamine